There was no news about Creative Medical Technology Inc (OTC: CELZ) on Tuesday, but it did not stop the stock from going on a strong rally.
Yesterday, Creative Medical Technology was in considerable focus among investors and recorded strong trading volumes as it rallied by as high as 52%. The last major development with regards to the biotech company emerged last month when Creative Medical Technology made an announcement with regards to its product ImmeCelz.
The product in question is meant for treating stroke victims and the company announced that the United States Food and Drug Administration issued it with an IND number in relation to its clinical trial. That was a significant development for the company and marked a significant milestone for the company. While that may be a trigger for the latest gains made by the stock, it might be worthwhile for investors to keep an eye on the news wires regarding Creative Medical Technology.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life